Working… Menu
Trial record 1 of 1 for:    DHES0815A
Previous Study | Return to List | Next Study

Safety, Tolerability, and Pharmacokinetic (PK) Study of DHES0815A in Participants With Human Epidermal Growth Factor Receptor (HER)2-Positive Breast Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03451162
Recruitment Status : Completed
First Posted : March 1, 2018
Last Update Posted : July 14, 2021
Information provided by (Responsible Party):
Genentech, Inc.

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : June 14, 2021
Actual Study Completion Date : June 14, 2021